UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report:
(Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State of Incorporation) |
(Commission File Number) |
(IRS employer Identification No.) |
|
||
(Address of principal executive offices) | (Zip Code) |
(Registrant’s telephone number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading symbol(s) |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01. | Regulation FD Disclosure. |
On August 26, 2022, Xperi Inc. (“Xperi Inc.”), a wholly owned subsidiary of Xperi Holding Corporation (the “Company”), publicly filed a registration statement on Form 10 (the “Form 10”) with the U.S. Securities and Exchange Commission (the “SEC”) relating to the intended separation and distribution (the “Spin-Off”) of the product business of the Company into Xperi Inc., which will be an independent, publicly-traded holding company upon the completion of the Spin-Off.
In addition to disclosing financial results of Xperi Inc. calculated in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) (Exhibit 99.1 of this Current Report), Exhibit 99.2 contains non-GAAP financial measures of Xperi Inc. adjusted for either one-time or ongoing non-cash acquired intangibles amortization charges; depreciation expense; all forms of stock-based compensation; other income/expense; interest expense; costs related to actual or planned business combinations including transaction fees, integration costs, severance, facility closures and retention bonuses. Management believes that the non-GAAP measures used in Exhibit 99.2 provide investors with important perspectives into the Company’s ongoing business and financial performance and provide a better understanding of our core operating results reflecting our normal business operations. The non-GAAP financial measures disclosed by the Company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP. Our use of non-GAAP financial measures has certain limitations in that the non-GAAP financial measures we use may not be directly comparable to those reported by other companies. We seek to compensate for the limitation of our non-GAAP presentation by providing, in Exhibit 99.2, a detailed reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures.
The information in this Item 7.01, including Exhibits 99.1 and 99.2, is being furnished with the Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits
The following exhibits are being furnished as part of this Current Report:
Exhibit |
Description of Exhibit | |
99.1 | GAAP Financial Information of Xperi Inc. | |
99.2 | Non-GAAP Reconciliations of Xperi Inc. |
The following exhibit is being filed as part of this report:
Exhibit |
Description of Exhibit | |
104 | Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: August 26, 2022 | ||||||
By: | /s/ Robert Andersen | |||||
Robert Andersen | ||||||
Chief Financial Officer |
Exhibit 99.1
XPERI INC.
UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET
AS OF JUNE 30, 2022
($ in thousands) |
Historical | Transaction Accounting Adjustments |
Notes | Autonomous Entity Adjustments |
Notes | Other Adjustments |
Notes | Pro Forma |
||||||||||||||||||||||||
ASSETS |
||||||||||||||||||||||||||||||||
Current assets: |
||||||||||||||||||||||||||||||||
Cash and cash equivalents |
$ | 133,257 | $ | 66,743 | (A) | $ | | $ | | $ | 200,000 | |||||||||||||||||||||
Accounts receivable, net |
79,606 | | | | 79,606 | |||||||||||||||||||||||||||
Unbilled contracts receivable, net |
46,487 | | | | 46,487 | |||||||||||||||||||||||||||
Other current assets |
30,690 | | | | 30,690 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total current assets |
$ | 290,040 | $ | 66,743 | $ | | $ | | $ | 356,783 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Long-term unbilled contracts receivable |
$ | 3,217 | $ | | $ | | $ | | $ | 3,217 | ||||||||||||||||||||||
Property and equipment, net |
53,573 | | | | 53,573 | |||||||||||||||||||||||||||
Operating lease right-of-use assets |
54,919 | | | | 54,919 | |||||||||||||||||||||||||||
Intangible assets, net |
241,583 | 17,294 | (B) | | 50,000 | (F) | 308,877 | |||||||||||||||||||||||||
Goodwill |
536,441 | | | | 536,441 | |||||||||||||||||||||||||||
Other assets |
27,939 | | | | 27,939 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total assets |
$ | 1,207,712 | $ | 84,037 | $ | | $ | 50,000 | $ | 1,341,749 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
LIABILITIES AND EQUITY |
||||||||||||||||||||||||||||||||
Current liabilities: |
||||||||||||||||||||||||||||||||
Accounts payable |
11,197 | | | | 11,197 | |||||||||||||||||||||||||||
Accrued liabilities |
73,920 | 1,523 | (C) | | | 75,443 | ||||||||||||||||||||||||||
Deferred revenue |
27,163 | | | | 27,163 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total current liabilities |
$ | 112,280 | $ | 1,523 | $ | | $ | | $ | 113,803 | ||||||||||||||||||||||
Long-term deferred tax liabilities |
15,135 | | | | 15,135 | |||||||||||||||||||||||||||
Long-term debt, net |
| | | 50,000 | (F) | 50,000 | ||||||||||||||||||||||||||
Deferred revenue, less current portion |
19,237 | | | | 19,237 | |||||||||||||||||||||||||||
Noncurrent operating lease liabilities |
42,571 | | | | 42,571 | |||||||||||||||||||||||||||
Other long-term liabilities |
4,142 | | | | 4,142 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total liabilities |
$ | 193,365 | $ | 1,523 | $ | | $ | 50,000 | 244,888 | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Equity: |
||||||||||||||||||||||||||||||||
Net Parent company investment |
$ | 1,029,487 | $ | (1,029,487 | ) | (D) | $ | | $ | | | |||||||||||||||||||||
Common stock |
| 42 | (D) | | | 42 | ||||||||||||||||||||||||||
Additional paid-in capital |
| 1,111,959 | (E) | | |
|
|
(F) | 1,111,959 | |||||||||||||||||||||||
Accumulated other comprehensive loss |
(4,125 | ) | | | | (4,125 | ) | |||||||||||||||||||||||||
Noncontrolling interest |
(11,015 | ) | | | | (11,015 | ) | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total equity |
$ | 1,014,347 | $ | 82,514 | $ | | $ | | $ | 1,096,861 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Total liabilities and equity |
$ | 1,207,712 | $ | 84,037 | $ | | $ | 50,000 | $ | 1,341,749 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
See accompanying notes to the unaudited pro forma condensed combined financial statements.
XPERI INC.
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
SIX MONTHS ENDED JUNE 30, 2022
($ in thousands except per share data) |
Historical | Transaction Accounting Adjustments |
Notes | Autonomous Entity Adjustments |
Notes | Other Adjustments |
Notes | Pro forma |
||||||||||||||||||||||||
Revenue |
$ | 245,092 | $ | | $ | | $ | 245,092 | ||||||||||||||||||||||||
Operating expenses: |
||||||||||||||||||||||||||||||||
Cost of revenue, excluding depreciation and amortization of intangible assets |
54,286 | | 54,286 | |||||||||||||||||||||||||||||
Research and development |
101,572 | (255 | ) | (G) | | 101,317 | ||||||||||||||||||||||||||
Selling, general and administrative |
100,193 | | (510 | ) | (J) | 99,683 | ||||||||||||||||||||||||||
Depreciation expense |
10,707 | | | 10,707 | ||||||||||||||||||||||||||||
Amortization expense |
29,553 | 1,092 | (H) | | 30,645 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total operating expenses |
296,311 | 837 | (510 | ) | | 296,638 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Operating loss |
(51,219 | ) | (837 | ) | 510 | (51,546 | ) | |||||||||||||||||||||||||
Interest expense |
(1,500 | ) | (K) | (1,500 | ) | |||||||||||||||||||||||||||
Other income and expense, net |
226 | | | 226 | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Loss before taxes |
(50,993 | ) | (837 | ) | 510 | (1,500 | ) | (52,820 | ) | |||||||||||||||||||||||
Provision for (benefit from) income taxe |
10,475 | (201 | ) | (I) | 122 | (I) | (360 | ) | (I) | 10,036 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Net loss |
(61,468 | ) | (636 | ) | 388 | (1,140 | ) | (62,856 | ) | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Less: Net loss attributable to noncontrolling interest |
(1,816 | ) | | | | (1,816 | ) | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Net loss attributable to Xperi Product |
$ | (59,652 | ) | $ | (636 | ) | 388 | (1,140 | ) | $ | (61,040 | ) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
Basic and diluted loss per share (Note L) |
$ | (1.46 | ) | |||||||||||||||||||||||||||||
Weighted average shares, basic and diluted (Note L) |
41,707,171 |
See accompanying notes to the unaudited pro forma condensed combined financial statements.
XPERI INC.
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
YEAR ENDED DECEMBER 31, 2021
($ in thousands except per share data) |
Historical | Transaction Accounting Adjustments |
Notes | Autonomous Entity Adjustments |
Notes | Other Adjustments |
Notes | Pro Forma |
||||||||||||||||||||
Revenue |
$ | 486,483 | $ | | $ | | $ | 486,483 | ||||||||||||||||||||
Operating expenses: |
||||||||||||||||||||||||||||
Cost of revenue, excluding depreciation and amortization of intangible assets |
125,626 | | 125,626 | |||||||||||||||||||||||||
Research and development |
194,869 | (510 | ) | (G) | | 194,359 | ||||||||||||||||||||||
Selling, general and administrative |
199,921 | | (1,020 | ) | (J | ) | 198,901 | |||||||||||||||||||||
Depreciation expense |
22,584 | | | 22,584 | ||||||||||||||||||||||||
Amortization expense |
105,311 | 2,185 | (H) | | 107,496 | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total operating expenses |
648,311 | 1,675 | (1,020 | ) | | 648,966 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Operating loss |
(161,828 | ) | (1,675 | ) | 1,020 | (162,483 | ) | |||||||||||||||||||||
Interest expense |
(3,000 | ) | (K) | (3,000 | ) | |||||||||||||||||||||||
Other income and expense, net |
1,590 | 1,590 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Loss before taxes |
(160,238 | ) | (1,675 | ) | 1,020 | (3,000 | ) | (163,893 | ) | |||||||||||||||||||
Provision for (benefit from) income taxes |
18,840 | (402 | ) | (I) | 245 | (I | ) | (720 | ) | (I) | 17,963 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Net loss |
(179,078 | ) | (1,273 | ) | 775 | (2,280 | ) | (181,856 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Less: Net loss attributable to noncontrolling interest |
(3,456 | ) | (3,456 | ) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net loss attributable to Xperi Product |
$ | (175,622 | ) | $ | (1,273 | ) | $ | 775 | $ | (2,280 | ) | $ | (178,400 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Basic and diluted loss per share (Note L) |
$ | (4.28 | ) | |||||||||||||||||||||||||
Weighted average shares, basic and diluted (Note L) |
|
41,707,171 |
See accompanying notes to the unaudited pro forma condensed combined financial statements.
NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
The unaudited pro forma condensed combined balance sheet as of June 30, 2022 includes the following pro forma adjustments:
Transaction Accounting Adjustments:
(A) | Reflects the capital contribution of approximately $66.7 million in cash paid to Xperi Inc. from Xperi Holding Corporation in connection with the Internal Reorganization and Business Realignment, separation and distribution as of June 30, 2022. |
(B) | Reflects patent assets, in the amount of $17.3 million, being transferred from Xperi Holding Corporation to Xperi Inc., in connection with the Internal Reorganization. While the patent assets are being transferred at fair value, they are recorded in the unaudited condensed combined pro forma balance sheet at their carryover basis, and therefore the value is not necessarily reflective of the fair value of the patent assets, individually or in total, nor can the fair value be ascertained on a per asset basis. |
(C) | In connection with the separation, Xperi Holding Corporation will transfer compensation related liabilities of $1.5 million for corporate employees transferred to Xperi Inc. for which the full accrual will be paid by Xperi Inc. when it comes due. |
(D) | Represents the reclassification of Xperi Holding Corporations net investment in Xperi Inc. to common stock and additional paid-in capital to reflect the number of shares of Xperi Inc. common stock expected to be outstanding at the distribution date. Reflects the issuance of 41,707,171 shares of our common stock with a par value of $0.001 per share pursuant to the Separation and Distribution Agreement. We have assumed the number of outstanding shares of our common stock based on 104,267,929 shares of Xperi common stock outstanding on August 1, 2022, and assuming a distribution of 100% of our common stock to Xperis stockholders and a distribution ratio of four shares of our common stock for every ten shares of Xperi common stock. The actual number of shares issued will not be known until the record date for the distribution. |
(E) | The additional paid-in-capital adjustments are summarized below: |
($ in thousands) | ||||
Cash and cash equivalents |
66,743 | |||
Intangible assets, net |
17,294 | |||
Accrued liabilities |
(1,523 | ) | ||
Net Parent company investment |
1,029,487 | |||
Common stock |
(42 | ) | ||
|
|
|||
Additional paid-in capital |
$ | 1,111,959 | ||
|
|
Other Adjustments
(F) | Reflects the senior unsecured promissory note issued by TiVo Product Holdco LLC on July 1, 2022 in connection with financing the consideration paid for the Vewd Acquisition. The promissory note bears an interest rate of 6.0% per annum, payable on a quarterly basis. The interest rate might be adjusted in connection with the separation and distribution. See the section entitled Description of Material Indebtedness for more information. Given the timing of the transaction, the purchase price allocation has not yet been completed. |
The unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2022 and for the year ended December 31, 2021 include the following pro forma adjustments:
Transaction Accounting Adjustments:
(G) | Reflects the net patent prosecution costs associated with the transferred intangible assets from Xperi Holding Corporation to Xperi Inc., offset by the transfer of intangible assets from Xperi Inc. to Xperi Holding Corporation, both in connection with the Internal Reorganization. |
(H) | Reflects the amortization expense associated with the transferred intangible assets from Xperi Holding Corporation to Xperi Inc. in connection with the Internal Reorganization. |
(I) | Reflects the tax effects of the unaudited pro forma adjustments calculated at the statutory rate of 24% based on the statutory rate for the respective jurisdiction. Management believes the statutory tax rate provides a reasonable basis for the pro forma adjustment. However, the effective tax rate of Xperi Inc. could be significantly different depending on actual operating results by jurisdiction and the application of enacted tax law to those specific results. |
Autonomous Entity Adjustments:
(J) | Reflects the reimbursement of general and administrative expense associated with post separation services provided by Xperi Inc. to Adeia post separation. |
Other Adjustments
(K) | Reflects the estimated interest expense associated with the issuance of the promissory note in connection with the Vewd Acquisition, which bears an interest rate of 6.0% per annum. |
Earnings (Loss) Per Share:
(L) | The numbers of Xperi Inc. shares used to compute basic and diluted earnings per share for the six months ended June 30, 2022 and for the year ended December 31, 2021 are based on the number of shares of Xperi Inc. common stock which are expected to be outstanding upon completion of the distribution. We have assumed the number of outstanding shares of common stock based on the number of Xperi Inc. common shares outstanding at August 1, 2022, assuming the anticipated distribution ratio of four shares of Xperi Inc. common stock for every ten shares of Xperi Holding Corporation common stock outstanding. Diluted weighted-average pro forma shares is the same as basic weighted-average pro forma shares because the potentially dilutive equity plans to purchase additional shares were not assumed to have been exercised if their effect is anti-dilutive. |
The adjustments shown in the tables below include those that management deems necessary to enhance the understanding of the pro forma effects of the Internal Reorganization, Business Realignment and separation and distribution. The following discussion contains forward-looking statements that reflect the plans, estimates and beliefs of management. The matters discussed in these forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those set forth in the forward-looking statements. See Cautionary Statement Concerning Forward-Looking Statements.
Following the separation, Xperi Inc. expects to incur costs as a standalone public company in connection with certain of its corporate functions including, but not limited to, marketing and other general and administrative functions, that are incremental to Xperi Inc.s corporate and shared costs allocated in the historical combined financial statements. Xperi Inc. performed a budget assessment of the resources and associated costs required to function as a stand-alone company. This assessment was performed consistently across all functions. The corporate support functions personnel-based adjustments presented in the tables below represent incremental expenses for personnel and stock-based compensation related to executive officers and other employees, who were considered shared as part of corporate allocations in the historical combined financial statements but will be employees of Xperi Inc. after the separation. The corporate support functions non-personnel-based adjustments presented in the tables below represent costs associated with outside services, legal, marketing, and investor relations fees and were determined by estimating third-party spend in each function.
Xperi Inc. benefits from shared corporate expenses as a segment within Xperi Holding Corporation. In order to operate as a standalone public company, Xperi Inc. expects to incur higher expenses than the prior shared allocation due to dis-synergies. The adjustments below show these dis-synergies, which are represented by higher costs of $20.4 million for the year ended December 31, 2021 and $10.2 million for the six months ended June 30, 2022. Management also expects certain expenses to be lower than the prior shared allocation, resulting in synergies of $1.0 million and $0.5 million for the year ended December 31, 2021 and the six months ended June 30, 2022, respectively.
The tax effect of the management adjustments noted in the table below has been determined by applying the respective statutory tax rates to the aforementioned adjustments in jurisdictions where valuation allowances were not required.
Management believes the presentation of these adjustments is necessary to enhance an understanding of the pro forma effects of the Internal Reorganization, Business Realignment and separation and distribution, and that these adjustments reflect all adjustments that are, in the opinion of management, necessary to provide a fair statement of the pro forma financial information, aligned with the assessment described above. The additional expenses have been estimated based on assumptions that Xperi Inc.s management believes are reasonable. However, actual additional costs could be different from the estimates, and would depend on several factors, including economic environment and strategic decisions made in areas such as separation, selling and marketing, research and development, information technology and infrastructure. Xperi Inc. may increase or reduce investments, expenses, or resources in the future that are not included in management adjustments below.
The tables below set forth each management adjustment in forms of synergies and dis-synergies for the periods presented.
For the Six Months Ended June 30, 2022 |
Net loss attributable to Xperi Inc.* |
Basic and diluted loss per share |
Weighted average share |
|||||||||
($ in thousands except share and per share amounts) | ||||||||||||
Pro Forma* |
$ | (61,040 | ) | $ | (1.46 | ) | 41,707,171 | |||||
Management adjustments |
||||||||||||
Synergies |
||||||||||||
Corporate support functions personnel-based (1) |
214 | |||||||||||
Corporate support functions non-personnel-based (2) |
293 | |||||||||||
Dis-synergies |
||||||||||||
Corporate support functions personnel-based (3) |
(7,096 | ) | ||||||||||
Corporate support functions non-personnel-based (4) |
(3,112 | ) | ||||||||||
|
|
|
|
|
|
|||||||
Total Management adjustments |
(9,701 | ) | ||||||||||
|
|
|
|
|
|
|||||||
Tax effect |
2,328 | |||||||||||
|
|
|
|
|
|
|||||||
Pro forma net loss after management adjustments |
$ | (68,413 | ) | $ | (1.64 | ) | 41,707,171 | |||||
|
|
|
|
|
|
* | As shown in the unaudited pro forma condensed combined statement of operations for the six months ended June 30, 2022. |
(1) | Represents primarily general and administrative expenses related to financial planning. |
(2) | Represents primarily facilities costs. |
(3) | Represents primarily general and administrative expenses, selling and corporate marketing expenses, and stock-based compensation expense. |
(4) | Represents costs associated with outside services, equipment, materials and supplies, investor relations costs, depreciation, facilities and insurance costs. |
For the Year Ended December 31, 2021 |
Net loss attributable to Xperi Inc.* |
Basic and diluted loss per share |
Weighted average share |
|||||||||
($ in thousands except share and per share amounts) | ||||||||||||
Pro Forma* |
$ | (178,400 | ) | $ | (4.28 | ) | 41,707,171 | |||||
Management adjustments |
||||||||||||
Synergies |
||||||||||||
Corporate support functions personnel-based (1) |
428 | |||||||||||
Corporate support functions non-personnel-based (2) |
586 | |||||||||||
Dis-synergies |
||||||||||||
Corporate support functions personnel-based (3) |
(14,191 | ) | ||||||||||
Corporate support functions non-personnel-based (4) |
(6,224 | ) | ||||||||||
|
|
|
|
|
|
|||||||
Total Management adjustments |
(19,401 | ) | ||||||||||
|
|
|
|
|
|
|||||||
Tax effect |
4,656 | |||||||||||
|
|
|
|
|
|
|||||||
Pro forma net loss after management adjustments |
$ | (193,145 | ) | $ | (4.63 | ) | 41,707,171 | |||||
|
|
|
|
|
|
* | As shown in the unaudited pro forma condensed combined statement of operations for the year ended December 31, 2021. |
(1) | Represents primarily general and administrative expenses related to financial planning. |
(2) | Represents primarily facilities costs. |
(3) | Represents primarily general and administrative expenses, selling and corporate marketing expenses, and stock-based compensation expense. |
(4) | Represents costs associated with outside services, equipment, materials and supplies, investor relations costs, depreciation, facilities and insurance costs. |
Exhibit 99.2
XPERI INC.
GAAP TO NON-GAAP RECONCILIATIONS
(in thousands)
(unaudited)
Twelve Months Ended | Six Months Ended | |||||||
December 31, 2021 | June 30, 2022 | |||||||
GAAP Loss before taxes |
$ | (160,238 | ) | $ | (50,993 | ) | ||
Pro forma adjustments for transaction accounting |
(1,675 | ) | (837 | ) | ||||
Pro forma adjustments for autonomous entity |
1,020 | 510 | ||||||
Pro forma other adjustments |
(3,000 | ) | (1,500 | ) | ||||
Interest expense |
3,000 | 1,500 | ||||||
Other income |
(1,590 | ) | (226 | ) | ||||
Depreciation expense |
22,584 | 10,707 | ||||||
Amortization expense |
105,311 | 29,553 | ||||||
Merger and integration-related costs: |
||||||||
Transaction and other related costs recorded in selling, general and administrative |
| 2,058 | ||||||
Restructuring and asset impairment costs recorded in selling, general and administrative |
(818 | ) | | |||||
Severance and retention recorded in cost of revenue, excluding depreciation and amortization of intangible assets |
849 | 106 | ||||||
Severance and retention recorded in research, development and other |
2,681 | 97 | ||||||
Severance and retention recorded in selling, general and administrative |
2,890 | (35 | ) | |||||
Stock-based compensation expense: |
||||||||
Cost of revenue |
1,999 | 1,398 | ||||||
Research, development and other |
17,914 | 10,780 | ||||||
Selling, general and administrative |
22,873 | 11,501 | ||||||
|
|
|
|
|||||
Non-GAAP Adjusted EBITDA |
$ | 13,801 | $ | 14,619 | ||||
|
|
|
|